The cryptophycins as potent payloads for antibody drug conjugates

https://doi.org/10.1016/j.bmcl.2014.12.070Get rights and content

Abstract

The cryptophycins are a potent class of cytotoxic agents that were evaluated as antibody drug conjugate (ADC) payloads. Free cryptophycin analog 1 displayed cell activity an order of magnitude more potent than approved ADC payloads MMAE and DM1.

This potency increase was also reflected in the activity of the cryptophycin ADCs, attached via a either cleavable or non-cleavable linker.

References and notes (35)

  • C. Sessa et al.

    Eur. J. Cancer

    (2002)
  • M.J. Edelman et al.

    Lung Cancer

    (2003)
  • M.L. Linenberger et al.

    Blood

    (2001)
  • M.S.K. Sutherland et al.

    J. Biol. Chem.

    (2006)
  • R.V.J. Chari et al.

    Angew. Chem., Int. Ed.

    (2014)
  • F.-C. Bidard et al.

    Targeted Oncol.

    (2013)
  • J.M. Lambert

    Br. J. Clin. Pharmacol.

    (2013)
  • R.J.Y. Ho et al.

    J. Pharm. Sci.

    (2013)
  • J. Katz et al.

    Clin. Cancer Res.

    (2011)
  • S. Verma et al.

    Engl. J. Med.

    (2012)
  • J.M. Lambert et al.

    J. Med. Chem.

    (2014)
  • B.A. Teicher

    Curr. Opin. Oncol.

    (2014)
  • I. Sassoon et al.
  • R. Schwartz et al.

    J. Ind. Microbiol.

    (1990)
  • C.D. Smith et al.

    Cancer Res.

    (1994)
  • S. Eißler et al.

    Synthesis

    (2006)
  • J.J. Field et al.

    Bioorg. Med. Chem.

    (2014)
  • Cited by (44)

    • Carbamate–drug conjugates in drug delivery: structural and mechanistic considerations

      2023, Polymer-Drug Conjugates: Linker Chemistry, Protocols and Applications
    View all citing articles on Scopus
    View full text